Skip to main content

Summer Road LLC's Form 4 filing

Ocular Therapeutix, Inc (OCUL) · filed Sep 29, 2022

Accession no.
0001567619-22-017965
Filed
Sep 29, 2022
Trade date
Sep 27-29, 2022
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 3 non-derivative transactions. Open-market purchases total $689.3K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Summer Road LLCCIK 000160487310% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Sep 27, 2022Common Stock, $0.0001 par value per sharePPurchaseAcquired+130,000$4.68F4+$608,4006,074,761Indirect
Sep 28, 2022Common Stock, $0.0001 par value per sharePPurchaseAcquired+1,200$4.10F5+$4,9206,075,961Indirect
Sep 29, 2022Common Stock, $0.0001 par value per sharePPurchaseAcquired+18,800$4.04F6+$75,9526,094,761Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F4

Represents the weighted average set forth in this line item. On September 27, 2022, the Reporting Person acquired 130,000 shares of Common Stock at a weighted average price of $4.6794 (ranging from a low of $4.20 and a high of $5.31). Upon request by the SEC staff, the issuer or a security holder of the issuer, the Reporting Person will provide full information regarding the number of shares of Common Stock purchased or sold at each separate price.

Referenced by the price of 1 transaction in Table I.

F5

Represents the weighted average set forth in this line item. On September 28, 2022, the Reporting Person acquired 1,200 shares of Common Stock at a weighted average price of $4.10 (all shares were purchased at a price of $4.10 and therefore no range has been provided).

Referenced by the price of 1 transaction in Table I.

F6

Represents the weighted average set forth in this line item. On September 29, 2022, the Reporting Person acquired 18,800 shares of Common Stock at a weighted average price of $4.0419 (ranging from a low of $4.00 and a high of $4.10). Upon request by the SEC staff, the issuer or a security holder of the issuer, the Reporting Person will provide full information regarding the number of shares of Common Stock purchased or sold at each separate price.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)